drugset / Trial / NCT02985281
Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients
RandomizedFactorialOpen-labelTreatment
Summary
Evaluation of Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Egyptian Pediatric Patients With Chronic Hepatitis C Infection aged 10- 18 years old.
Timeline
- Start
- 2016-12
- Primary completion
- 2017-06
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ribavirin | Small molecule | 15 mg/kg | Oral |
| Comparator | Sofosbuvir | Small molecule | 200 mg | Oral |
| Comparator | Sofosbuvir | Small molecule | 300 mg | Oral |
| Comparator | Sofosbuvir | Small molecule | 400 mg | Oral |
Indications
No indication recorded.